Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis (clinicaltrials.gov) - Apr 1, 2026 - P4 | N=10 | Recruiting | Sponsor: First Hospital of China Medical University
New P4 trial • Immunology • Psoriasis
|